AD504

DRUG2 trials

Sponsors

Apnimed

Conditions

OSA - Obstructive Sleep ApneaObstructive Sleep Apnea

Phase 2

Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea

CompletedNCT04645524

ApnimedObstructive Sleep Apnea

Start: 2020-12-01End: 2021-09-01Updated: 2022-09-02

Parallel Arm Trial of AD109 and AD504 In Patients With OSA

CompletedNCT05071612

ApnimedOSA - Obstructive Sleep Apnea

Start: 2021-11-29End: 2022-08-03Updated: 2026-08-12

Related Papers

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.

2023-12-0147 citations

Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.

2023-06-0112 citations